The primary responsibility of the National Heart, Lung, and Blood Institute (NHLBI) is the scientific investigation of heart, blood vessel, lung, and blood diseases. NHLBI oversees resources and research, demonstration, prevention, education, control, and sleep disorders and training activities in these fields. The program emphasizes the prevention and control of heart, lung, and blood diseases and sleep disorders, and education concerning these diseases through more rapid transfer of knowledge into the mainstream of clinical medicine and personal health practices. Inquiries related to high blood pressure, cholesterol, asthma, and blood diseases, as well as any information requests associated with cardiovascular disease prevention and heart-health promotion are handled by the National Heart, Lung, and Blood Institute Health Information Center.
NHLBI provides information on such topics as heart disease, the heart, arteriosclerosis, congestive heart failure, chronic obstructive pulmonary disease, angina, Raynaud's disease, immune thrombocytopenic purpura, heart transplants, arrhythmias, valvular heart disease, and sickle cell disease. Topics of publications for professionals include arteriosclerosis, lipid research, fetal hemoglobinopathies, cardiovascular diseases, coronary heart disease, asthma, and aplastic anemia. A publications list is available.
You may search for other related entries in the database under the following topics.